This is a video synopsis/summary of an Insights involving Allison Wheeler, MD. Wheeler addresses the nuanced considerations for implementing prophylaxis in patients with mild to moderate hemophilia A, ...

Dr. William Farrar answers the question: 'What is a prophylactic mastectomy?' — -- Question: What is a prophylactic mastectomy and am I still at risk for breast cancer if I have this surgery?

The COCOON trial assessed prophylactic dermatologic regimens in NSCLC patients treated with amivantamab and lazertinib, showing reduced AEs and improved quality of life. Prophylactic treatment ...

Purpose The Drusen Laser Study (DLS) of high-risk age-related maculopathy (ARM) is a randomised, controlled clinical trial designed to answer two questions: (1) Do drusen resolve after macular laser ...

New FRONTIER5 results show a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for a washout period, was well-tolerated in adults and ...

Baxter International Inc. (NYSE:BAX) today announced that the United States Food and Drug Administration (FDA) granted approval of Baxter's FEIBA [Anti-Inhibitor Coagulant Complex], the first and only ...

Young patients with hemophilia have suboptimal adherence to recombinant prophylactic treatment—an important means of reducing morbidity and mortality and improving health-related quality of life ...

A recent follow-up to a 2007 study examined trends in prophylaxis treatment of hemarthrosis in a pediatric population with moderate-to-severe hemophilia A. Discharge codes were used to track bleeding ...

FDA approval is based on phase 3 trial data (explorer8), which established the safety and efficacy of Alhemo ® (concizumab-mtci) injection in people 12 years and older with hemophilia A or B (HA/HB) ...

Hospitalization is often associated with acute physical and psychological distress. This is due to not only to the illness per se that precipitated the hospitalization, but also to hospitalization ...